Kidney and Metabolic Bone Diseases Vol.14 No.2(7)

Theme Frontiers in Vitamin D Action
Title Immunomodulating action of vitamin D
Publish Date 2001/04
Author Yoshiko Sowa Department of Environmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health
Author Keiichi Ozono Department of Environmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health / Department of Hygienic Science, Kobe Pharmaceutical University
[ Summary ] Several lines of evidence including the existence of the vitamin D receptor (VDR) in cells involved in the immune response suggest the physiological role of 1,25-dihydroxyvitamin D, the active form of vitamin D in immune system. There are many reports describing that 1,25-dihydroxyvitamin D suppresses the production of cytokines such as in terleukin-2, interferon-γ and GM-CSF (granulocyte macrophage colony stimulating factor) in T cells. The transcription factor, NFAT, and VDR mediate the suppressive effect of 1,25-dihydroxyvitamin D. However, the precise mechanism in which these molecules interact with each other on the promoter regions of cytokines genes is different in various cytokines. 1,25-dihydroxyvitamin D also inhibits the function of antigen-presenting cells leading to the immunosuppression. The in vivo data demonstrate that 1,25-dihydroxyvitamin D exerts some effects in autoimmune diseases and the rejection of transplanted organs. Since 1,25-dihydroxyvitamin D has a relatively mild modulating effect on immune response and adverse effects, especially increases in serum calcium levels, it is necesary to develop new vitamin D analogues which addresses these problems.
back